Clinical Trial Update: A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 dose-escalation trial assesses ombrabulin in combination with paclitaxel and carboplatin in patients with advanced solid tumors, focusing on safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Ombrabulin (ombrabulin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sanofi | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED